Iridex (IRIX) Deferred Taxes (2015 - 2016)

Iridex (IRIX) recorded quarterly Deferred Taxes of $9.0 million in Q4 2016, up 5888.67% quarter-over-quarter from $150000.0 in Q2 2015.

Iridex (IRIX) Deferred Taxes (2015 - 2016) Analysis & Trends

Iridex's Deferred Taxes history runs 2 years deep, the most recent figure standing at $9.0 million for Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -33.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -101.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -9.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 300,000.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -16.70 Mn
10 Iridex 19.91 Mn 15.31 Mn 4.74 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2016 8.98 Mn
Apr 4, 2015 150,000.00